|
|
Volumn 71, Issue 1, 2016, Pages 88-90
|
|
US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis: Executive summary
a,b
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMIKACIN;
AZITHROMYCIN;
CEFOXITIN;
CLARITHROMYCIN;
CLOFAZIMINE;
ETHAMBUTOL;
IMIPENEM;
LINEZOLID;
MINOCYCLINE;
MOXIFLOXACIN;
RIFAMPICIN;
STREPTOMYCIN;
TIGECYCLINE;
TUBERCULOSTATIC AGENT;
ACID FAST BACTERIUM;
ANTIBIOTIC RESISTANCE;
ANTIBIOTIC SENSITIVITY;
ARTICLE;
BACTERIUM CULTURE;
BACTERIUM ISOLATE;
CONSENSUS DEVELOPMENT;
CYSTIC FIBROSIS;
DRUG INDICATION;
EVIDENCE BASED PRACTICE;
HUMAN;
LUNG LAVAGE;
LUNG RESECTION;
LUNG TRANSPLANTATION;
MEDICAL PRACTICE;
METHODOLOGY;
MONOTHERAPY;
MYCOBACTERIUM;
MYCOBACTERIUM ABSCESSUS;
MYCOBACTERIUM AVIUM COMPLEX;
MYCOBACTERIUM CHIMAERA;
MYCOBACTERIUM INTRACELLULARE;
NEPHROTOXICITY;
NONHUMAN;
OTOTOXICITY;
PRIORITY JOURNAL;
SPUTUM ANALYSIS;
SYSTEMATIC REVIEW (TOPIC);
THROAT CULTURE;
TRANSBRONCHIAL BIOPSY;
TREATMENT DURATION;
TREATMENT INDICATION;
COMPLICATION;
CONSENSUS;
DISEASE MANAGEMENT;
EUROPE;
MEDICAL SOCIETY;
MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS;
UNITED STATES;
ANTITUBERCULAR AGENTS;
CONSENSUS;
CYSTIC FIBROSIS;
DISEASE MANAGEMENT;
EUROPE;
HUMANS;
MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS;
SOCIETIES, MEDICAL;
UNITED STATES;
|
|
EID: 84958211439
PISSN: 00406376
EISSN: 14683296
Source Type: Journal
DOI: 10.1136/thoraxjnl-2015-207983 Document Type: Article |
|
Times cited : (387)
|
|
References (5)
|
